Skip header and navigation
Canadian Medical Association
  • CMA Policybase
  • Home
  • Help
  • Selections 0
  • Pharmaceuticals, prescribing, cannabis, drugs
  • Produits pharmaceutiques, ordonnances, cannabis, médicaments
  • 2017
  • Policy endorsement
Print PDF
Sort by Relevance Sort by Title Sort by Oldest
Gallery View Table View
Refine Your Search

Narrow Results By

Topic

  • Pharmaceuticals, prescribing, cannabis, drugs

Policy Type

  • Parliamentary submission 3
  • Policy document 1
  • Policy endorsement
  • Response to consultation 4

Year

  • 2021 1
  • 2018 1
  • 2017
  • Advanced Search
  • Help

1 records – page 1 of 1.

Prev Next
PD17-06 pdf thumbnail
Toggle Detail View

Canada’s lower-risk cannabis use guidelines (LRCUG)

https://policybase.cma.ca/link/policy13726
Date
2017-05-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs
More detail
1 document
Policy Type
Policy endorsement
Date
2017-05-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Documents
PD17-06 pdf thumbnail
Read PDF View as Flipbook Download PDF
Less detail
  • Share
    Facebook Facebook Twitter Twitter LinkedIn LinkedIn
  • Permalink
  • Privacy
  • Terms & Conditions
  • Accessibility
  • Contact

© 2022 Canadian Medical Association